Review



massarray platform iplex® gold assay design system  (Sequenom)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Sequenom massarray platform iplex® gold assay design system
    Summary of the publications included in this review that report differential responses to antiretroviral medications.
    Massarray Platform Iplex® Gold Assay Design System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/massarray platform iplex® gold assay design system/product/Sequenom
    Average 90 stars, based on 1 article reviews
    massarray platform iplex® gold assay design system - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review"

    Article Title: The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review

    Journal: Frontiers in Genetics

    doi: 10.3389/fgene.2021.698825

    Summary of the publications included in this review that report differential responses to antiretroviral medications.
    Figure Legend Snippet: Summary of the publications included in this review that report differential responses to antiretroviral medications.

    Techniques Used: Medications, Sequencing, Infection, Iplex Gold Assay, Western Blot, Formulation, TaqMan Assay, Electrophoresis

    Summary of the publications included in this review that report differential responses to “other” medications.
    Figure Legend Snippet: Summary of the publications included in this review that report differential responses to “other” medications.

    Techniques Used: Medications, Sequencing, Iplex Gold Assay, Long Range PCR, Amplification, Purification



    Similar Products

    massarray platform iplex® gold assay design system  (Sequenom)
    90
    Sequenom massarray platform iplex® gold assay design system
    Summary of the publications included in this review that report differential responses to antiretroviral medications.
    Massarray Platform Iplex® Gold Assay Design System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/massarray platform iplex® gold assay design system/product/Sequenom
    Average 90 stars, based on 1 article reviews
    massarray platform iplex® gold assay design system - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of the publications included in this review that report differential responses to antiretroviral medications.

    Journal: Frontiers in Genetics

    Article Title: The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review

    doi: 10.3389/fgene.2021.698825

    Figure Lengend Snippet: Summary of the publications included in this review that report differential responses to antiretroviral medications.

    Article Snippet: Guzmán-Fulgencio et al. ( ) , 304 HIV/HCV coinfected patients who had completed a course of HCV therapy , PegIFN-α/ribavirin therapy , Genotyping was performed using the Sequenom MassARRAY platform iPLEX® Gold assay design system , SVR following pegIFN-α + ribavirin treatment , European mtDNA haplogroups were not related to HCV treatment response in HIV/HCV coinfected patients on pegIFN-α/ribavirin therapy , Multiple/Multiple/>0.05.

    Techniques: Medications, Sequencing, Infection, Iplex Gold Assay, Western Blot, Formulation, TaqMan Assay, Electrophoresis

    Summary of the publications included in this review that report differential responses to “other” medications.

    Journal: Frontiers in Genetics

    Article Title: The Role of Mitochondrial DNA Variation in Drug Response: A Systematic Review

    doi: 10.3389/fgene.2021.698825

    Figure Lengend Snippet: Summary of the publications included in this review that report differential responses to “other” medications.

    Article Snippet: Guzmán-Fulgencio et al. ( ) , 304 HIV/HCV coinfected patients who had completed a course of HCV therapy , PegIFN-α/ribavirin therapy , Genotyping was performed using the Sequenom MassARRAY platform iPLEX® Gold assay design system , SVR following pegIFN-α + ribavirin treatment , European mtDNA haplogroups were not related to HCV treatment response in HIV/HCV coinfected patients on pegIFN-α/ribavirin therapy , Multiple/Multiple/>0.05.

    Techniques: Medications, Sequencing, Iplex Gold Assay, Long Range PCR, Amplification, Purification